ConductScience.org, home

Paper31938457

Fluorescence Labeling of Neurotensin(8-13) via Arginine Residues Gives Molecular Tools with High Receptor Affinity.

Keller M and 10 others. ACS Med Chem Lett, 2020. Cited by 24 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Fluorescence Labeling of Neurotensin(8-13) via Arginine Residues Gives Molecular Tools with High Receptor Affinity. Papers, record 31938457. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31938457

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Fluorescence Labeling of Neurotensin(8-13) via Arginine Residues Gives Molecular Tools with High Receptor Affinity.
PubMed
Journal
ACS Med Chem Lett
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
1.22
iCite
Revised in PubMed
2020-09-30
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Keller MMax
2Mahuroof SAShahani A
3Hong Yee VVivyanne
4Carpenter JJessica
5Schindler LLisa
6Littmann TTimo
7Pegoli AAndrea
8Hübner HHarald
9Bernhardt GGünther
10Gmeiner PPeter
11Holliday NDNicholas D

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128,970,469Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors.Nat Commun2017https://conductscience.org/library/papers/28970469PubMed
218,781,940Fluorescent GPCR ligands as new tools in pharmacology.Curr Med Chem2008https://conductscience.org/library/papers/18781940PubMed
39,616,318Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.Gut1998https://conductscience.org/library/papers/9616318PubMed
44,745,447The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami.J Biol Chem1973https://conductscience.org/library/papers/4745447PubMed
516,125,436Fluorophore-tagged GPCR ligands.Curr Opin Chem Biol2005https://conductscience.org/library/papers/16125436PubMed
625,010,291Portraying G protein-coupled receptors with fluorescent ligands.ACS Chem Biol2014https://conductscience.org/library/papers/25010291PubMed
78,189,037Synthesis of a biologically active fluorescent probe for labeling neurotensin receptors.J Histochem Cytochem1994https://conductscience.org/library/papers/8189037PubMed
815,468,079Chameleon labels for staining and quantifying proteins.Angew Chem Int Ed Engl2004https://conductscience.org/library/papers/15468079PubMed
916,901,585Internalization and recycling properties of neurotensin receptors.Peptides2006https://conductscience.org/library/papers/16901585PubMed
1010,803,605High throughput fluorescence polarization: a homogeneous alternative to radioligand binding for cell surface receptors.J Biomol Screen2000https://conductscience.org/library/papers/10803605PubMed
111,167,549The amino acid sequence of a hypothalamic peptide, neurotensin.J Biol Chem1975https://conductscience.org/library/papers/1167549PubMed
1221,446,649Discovery of highly potent and neurotensin receptor 2 selective neurotensin mimetics.J Med Chem2011https://conductscience.org/library/papers/21446649PubMed
138,381,365Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor.FEBS Lett1993https://conductscience.org/library/papers/8381365PubMed
1410,390,649Neurotensin and neurotensin receptors.Trends Pharmacol Sci1999https://conductscience.org/library/papers/10390649PubMed
1525,189,338Targeting neuropeptide receptors for cancer imaging and therapy: perspectives with bombesin, neurotensin, and neuropeptide-Y receptors.J Nucl Med2014https://conductscience.org/library/papers/25189338PubMed
1625,174,921Fluorescent GPCR ligands as new tools in pharmacology-update, years 2008-early 2014.Curr Med Chem2014https://conductscience.org/library/papers/25174921PubMed
1726,317,175Fluorescence- and bioluminescence-based approaches to study GPCR ligand binding.Br J Pharmacol2016https://conductscience.org/library/papers/26317175PubMed
1826,954,998Homogeneous time-resolved G protein-coupled receptor-ligand binding assay based on fluorescence cross-correlation spectroscopy.Anal Biochem2016https://conductscience.org/library/papers/26954998PubMed
197,084,220
Synthesis and characterization of neurotensin analogues for structure/activity relationship studies. Acetyl-neurotensin-(8--13) is the shortest analogue with full binding and pharmacological activities.
Eur J Biochem1982https://conductscience.org/library/papers/7084220PubMed
2010,934,036Ligand-induced internalization of neurotensin in transfected COS-7 cells: differential intracellular trafficking of ligand and receptor.J Cell Sci2000https://conductscience.org/library/papers/10934036PubMed

See all 34 references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
42,109,681Advances in neurotensin receptor 1-targeted molecular probes for tumor molecular imaging and therapy.Front Oncol2026https://conductscience.org/library/papers/42109681PubMed
40,899,861High-Affinity and Proteolytically Stable Peptidic Fluorescent NTS1R Ligands.J Med Chem2025https://conductscience.org/library/papers/40899861PubMed
40,574,01399mTc-Labeled Diarylpyrazoles for Single-Emission Computer Tomography Imaging of Neurotensin Receptor-Positive Tumors: A Comparative Preclinical Study.Pharmaceutics2025https://conductscience.org/library/papers/40574013PubMed
39,261,089Dually Labeled Neurotensin NTS1R Ligands for Probing Radiochemical and Fluorescence-Based Binding Assays.J Med Chem2024https://conductscience.org/library/papers/39261089PubMed
39,162,616Genetic code expansion, click chemistry, and light-activated PI3K reveal details of membrane protein trafficking downstream of receptor tyrosine kinases.Elife2024https://conductscience.org/library/papers/39162616PubMed
38,633,582Illuminating Neuropeptide Y Y4 Receptor Binding: Fluorescent Cyclic Peptides with Subnanomolar Binding Affinity as Novel Molecular Tools.ACS Pharmacol Transl Sci2024https://conductscience.org/library/papers/38633582PubMed
37,649,440A Biomimetic C-Terminal Extension Strategy for Photocaging Amidated Neuropeptides.J Am Chem Soc2023https://conductscience.org/library/papers/37649440PubMed
36,805,869Theranostic cobalt-55/58m for neurotensin receptor-mediated radiotherapy in vivo: A pilot study with dosimetry.Nucl Med Biol2023https://conductscience.org/library/papers/36805869PubMed
36,407,949Insertion of Nanoluc into the Extracellular Loops as a Complementary Method To Establish BRET-Based Binding Assays for GPCRs.ACS Pharmacol Transl Sci2022https://conductscience.org/library/papers/36407949PubMed
36,230,845Development of a Neurotensin-Derived 68Ga-Labeled PET Ligand with High In Vivo Stability for Imaging of NTS1 Receptor-Expressing Tumors.Cancers (Basel)2022https://conductscience.org/library/papers/36230845PubMed
36,056,076Neurotensin analogs by fluoroglycosylation at Nω-carbamoylated arginines for PET imaging of NTS1-positive tumors.Sci Rep2022https://conductscience.org/library/papers/36056076PubMed
34,665,963Screening and Quantification of the Encapsulation of Dyes in Supramolecular Particles.Langmuir2021https://conductscience.org/library/papers/34665963PubMed
32,832,018Fluorescent H2 Receptor Squaramide-Type Antagonists: Synthesis, Characterization, and Applications.ACS Med Chem Lett2020https://conductscience.org/library/papers/32832018PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31938457

GET https://conductscience.org/api/papers/v1/31938457/references?page=2